# Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Orthopedic Surgical Operations

> **NCT03232021** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Saint Savvas Anticancer Hospital**

## Conditions studied

- Pregabalin on Catheter Related Bladder Discomfort

## Interventions

- **DRUG:** Placebo oral capsule
- **DRUG:** Pregabalin Oral Capsule [Lyrica] 75mg
- **DRUG:** Pregabalin Oral Capsule [Lyrica] 150 mg

## Key facts

- **NCT ID:** NCT03232021
- **Lead sponsor:** Saint Savvas Anticancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-08-16
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-04-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** All patients during the study period were subjected to peripheral blocks or were excluded from the study due to exclusion criteria
- **Last updated:** 2020-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03232021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03232021, "Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Orthopedic Surgical Operations". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03232021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*